Hutch News

Hutch News

Stories tagged 'gvhd'

Stem cell transplantation physician-scientist recruited from Australia to join Fred Hutch, SCCA

Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies

Dec. 7, 2017 | By Molly McElroy

Fred Hutchinson Cancer Research Center is appointing world-renowned blood stem cell transplantation physician-scientist Dr. Geoffrey Hill to be director of Hematopoietic Stem Cell Transplantation, effective July 1.

View story >


'Back to normal life'

Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports

Dec. 5, 2016 | By Bill Briggs / Fred Hutch News Service

Patients in a clinical trial, including Dr. Curtis Mack, had lower rates of graft-vs.-host disease when researchers filtered stem cells before transplant, scientists reported Monday.

View story >


Three's a charm in a triple-drug combination for transplant patients

A drug with a storied past offers a new edge against an old foe

Dec. 4, 2016 | By Sabin Russell / Fred Hutch News Service

Discovered nearly 45 years ago in the volcanic soils of fabled Easter Island in the Pacific, a drug first thought of as an antifungal agent has found a new purpose by boosting the survival of leukemia patients after blood stem cell transplants. In a clinical trial conducted by Fred Hutchinson Cancer Research Center, the addition of a third drug, sirolimus, to a standard two-drug regimen effectively cut in half the incidence of acute graft-vs.-host disease, or GVHD, a common and dangerous complication of these lifesaving procedures.

View story >


The cost of survival

Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain

Nov. 4, 2016 | By Bill Briggs / Fred Hutch News Service

Some survivors say it’s hard for those untouched by cancer to understand the scales of life don’t always balance with survival on one side and a jumble of complications heaped on the other.

View story >


Which cells to choose?

New study explores whether stem cells from bone marrow or blood offer transplant patients better quality of life

Aug. 16, 2016 | By Susan Keown / Fred Hutch News Service

A new study of blood stem-cell transplant patients found no difference in survival between patients who received transplants derived from bone marrow versus those who received transplants derived from circulating blood stem-cells. However, the bone marrow transplant patients did experience fewer related symptoms and side effects.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Feb. 4, 2016 | By Fred Hutch News Service staff

Drs. Marie Bleakley and Soheil Meshinchi receive $1M to design targeted immunotherapies for childhood leukemia; pancreatic cancer treatment advancing in clinical trials; novel mathematical model could transform dosage selection for clinical trials; new global initiative for breast cancer has roots in Seattle; Dr. Colin Correnti speaks at inaugural SHIFT 2016

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.